CULLINAN THERAPEUTICS INC COM is a security (CUSIP 230031106) tracked across SEC portfolio filings. 183 institutional managers reported $893.2M on Form 13F as of 2026-06-30; 17 registered fund positions totaling $37.1M via N-PORT as of 2026-05-31.
Showing 15 of 183 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Lynx1 Capital Management LP | SAN JUAN, PR | $127.4M | 8,963,500 |
| MPM BIOIMPACT LLC | BOSTON, MA | $108.7M | 7,648,268 |
| BVF INC/IL | San Francisco, CA | $81.7M | 5,750,683 |
| BlackRock, Inc. | New York, NY | $63.2M | 4,449,966 |
| Kynam Capital Management, LP | PRINCETON, NJ | $44.3M | 3,114,132 |
| STATE STREET CORP | BOSTON, MA | $36.2M | 2,544,115 |
| VANGUARD GROUP INC | Valley Forge, PA | $34.1M | 3,298,504 |
| Blue Owl Capital Holdings LP | New York, NY | $27.1M | 1,909,764 |
| RTW INVESTMENTS, LP | NEW YORK, NY | $24.2M | 1,705,960 |
| VR Adviser, LLC | NEW YORK, NY | $19.6M | 1,379,965 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $19.4M | 1,368,268 |
| Siren, L.L.C. | New York, NY | $17.0M | 1,193,410 |
| Nextech Invest, Ltd. | Zurich, V8 | $16.2M | 1,141,145 |
| BOOTHBAY FUND MANAGEMENT, LLC | NEW YORK, NY | $15.8M | 1,112,803 |
| MARSHALL WACE, LLP | LONDON, X0 | $14.9M | 1,049,581 |
Showing 15 of 17 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $9.8M | 8.96% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $8.1M | 0.99% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $6.0M | 4.72% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $4.6M | 2.60% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $2.6M | 3.42% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $1.9M | 10.25% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $1.2M | 2.42% |
| Bridge Builder Tax Managed Small/Mid Cap Fund | Bridge Builder Trust | $736K | 2.43% |
| Fidelity Nasdaq Composite Index ETF | Fidelity Commonwealth Trust | $610K | 0.56% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $610K | 9.20% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $463K | 0.08% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $346K | 0.11% |
| DWS Small Cap Index VIP | DEUTSCHE DWS INVESTMENTS VIT FUNDS | $107K | 2.56% |
| CORNERCAP SMALL-CAP VALUE FUND | CORNERCAP GROUP OF FUNDS | $103K | 8.58% |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | Goldman Sachs ETF Trust | $86K | 0.87% |